StockData
Vogenx, Inc. logo

Vogenx, Inc. (VOGX) stock

VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$12.80+0.46 (+3.77%)

Close on Nov 19, 2026Market cap $190.22MP/E –Yield –

Vogenx free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Vogenx

Vogenx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Vogenx figures

See a number that looks wrong?